Stem cell therapy promising: Experts
New Kerala Fri, 11 Jul 2008 10:14 PM PDT
Manipal, Jul 12 : As the stem cell therapies were showing promising results for various diseases and currently used to meet unmet medical needs, the global market for such therapies was expected to be 20 billion US Dollar by 2010, Mr Ramdas M Pai, Chancellor of Manipal University, said here. |
Muscle stem cell advance hailed
BBC News Thu, 10 Jul 2008 11:34 PM PDT
Animal research raises the possibility that adult stem cell transplants may treat muscular dystrophy. |
Genes That Control Embryonic Stem Cell Fate Identified
BioresearchOnline Fri, 11 Jul 2008 6:06 AM PDT
Scientists have identified about two dozen genes that control embryonic stem cell fate. The genes may either prod or restrain stem cells from drifting into a kind of limbo, they suspect. The limbo lies between the embryonic stage and fully differentiated, or specialized, cells, such as bone, muscle or fat |
Muscle Stem Cell Transplant Boosts Diseased Muscle Function And Replenishes Stem Cell Pool
Medical News Today Fri, 11 Jul 2008 3:06 AM PDT
Researchers at the Joslin Diabetes Center have demonstrated for the first time that transplanted muscle stem cells can both improve muscle function in animals with a form of muscular dystrophy and replenish the stem cell population for use in the repair of future muscle injuries. "I'm very excited about this," said lead author Amy J. Wagers, Ph.D. |
Stem cell transplant for sickle cell disease subject of clinical trial
Washington University School of Medicine Fri, 11 Jul 2008 1:57 PM PDT
July 11, 2008 -- Children with sickle cell disease often face severe pain, organ damage, recurrent strokes and repeated, prolonged hospital stays. Although there are medical interventions that can lessen the symptoms, there is no cure. |
ISCO collaborates with Michigan State University to study parthenogenetic stem cells
PharmaBiz Fri, 11 Jul 2008 1:48 AM PDT
International Stem Cell Corporation (ISCO) announced a new collaboration with leading stem cell researcher Jose Cibelli at Michigan State University as part of ISCO's ongoing strategy to work with scientific leaders across the world to expand the scientific data relating to parthenogenetic stem cells. |
Mesoblast Limited Announce Pre-Clinical Trials Show Allogenic Stem Cells Effectively Treat Eye Diseases
Medical News Today Fri, 11 Jul 2008 3:08 AM PDT
Australia's regenerative medicine company, Mesoblast Limited (ASX:MSB; USOTC: MBLTY), announced highly significant preclinical trial results of the adult stem cell technology platform for the treatment of eye diseases associated with abnormal blood vessels. These diseases include diabetic retinopathy and age-related macular degeneration (AMD), the leading causes of blindness in the western world. |
Stem Cell Treatment for Children with Eye Nerve Disease Called 'Medical Hoax'
Newswise Fri, 11 Jul 2008 10:24 AM PDT
Two pediatric eye surgeons at Washington University School of Medicine in St. Louis expressed alarm over what they label a "21st century snake oil" scam. They are concerned that reports will mislead many parents of children with optic nerve hypoplasia, who may bankrupt savings, go deeply into debt or organize fundraisers to pay for sham treatment. |
| |
|
